Gastric and ectopic varices

Clinics in Liver Disease

Volumn 18, Issue 2, 2014, Pages 371-388

  Henry, Zachary ^a   Uppal, Dushant ^a   Saad, Wael ^a   Caldwell, Stephen ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

BRTO; Duodenal varices; Ectopic varices; Gastric varices; Portal vein thrombosis; Rectal varices; Splenic vein thrombosis; TIPS

Indexed keywords

AMINOCAPROIC ACID; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYANOACRYLATE; ENBUCRILATE; OCTREOTIDE; THROMBIN; VASOPRESSIN DERIVATIVE; CYANOACRYLATE DERIVATIVE; TISSUE ADHESIVE;

ANTICOAGULATION; BALLOON OCCLUDED RETROGRADE TRANSVENOUS OBLITERATION; BLEEDING; COLORECTAL VARICES; DUODENAL VARICES; DUODENAL VARICES BLEEDING; ECTOPIC VARICES; ECTOPIC VARICES BLEEDING; EMBRYO DEVELOPMENT; ENDOSCOPIC THERAPY; FOLLOW UP; HUMAN; LIGATION; LIVER CIRRHOSIS; LIVER TAMPONADE; MINIMALLY INVASIVE PROCEDURE; PORTAL VEIN THROMBOSIS; RECTAL VARICES; REVIEW; RISK BENEFIT ANALYSIS; SPLEEN VEIN THROMBOSIS; SPLENECTOMY; STOMACH VARICES; STOMACH VARICES BLEEDING; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT; VARICEAL BAND LIGATION; VARICOSIS; VEIN THROMBOSIS; ALGORITHM; BALLOON OCCLUSION; CLASSIFICATION; COMPLICATION; EMBRYOLOGY; ESOPHAGEAL AND GASTRIC VARICES; GASTROINTESTINAL ENDOSCOPY; HYPERTENSION, PORTAL; MULTIMODALITY CANCER THERAPY; PORTAL VEIN;

ADRENERGIC BETA-ANTAGONISTS; ALGORITHMS; BALLOON OCCLUSION; COMBINED MODALITY THERAPY; CYANOACRYLATES; ENDOSCOPY, GASTROINTESTINAL; ESOPHAGEAL AND GASTRIC VARICES; HUMANS; HYPERTENSION, PORTAL; LIGATION; LIVER CIRRHOSIS; PORTAL SYSTEM; PORTAL VEIN; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; TISSUE ADHESIVES; VENOUS THROMBOSIS;

EID: 84897071895     PISSN: 10893261     EISSN: 15578224     Source Type: Journal    
DOI: 10.1016/j.cld.2014.01.002     Document Type: Review

References (99)

1. Evans G.R., Yellin A.E., Weaver F.A., et al. Sinistral (left-sided) portal hypertension. Am Surg 1990, 56(12):758-763.
2. Patten B.M., Carlson B.M. Patten's foundations of embryology 1996, 752. McGraw-Hill, New York, xii. 6th edition.
3. Kim T., Shijo H., Kokawa H., et al. Risk factors for hemorrhage from gastric fundal varices. Hepatology 1997, 25(2):307-312.
4. Sarin S.K., Lahoti D., Saxena S.P., et al. Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients. Hepatology 1992, 16(6):1343-1349.
5. Maruyama H., Ishihara T., Ishii H., et al. Blood flow parameters in the short gastric vein and splenic vein on Doppler ultrasound reflect gastric variceal bleeding. Eur J Radiol 2010, 75(1):e41-e45.
6. Watanabe K., Kimura K., Matsutani S., et al. Portal hemodynamics in patients with gastric varices. A study in 230 patients with esophageal and/or gastric varices using portal vein catheterization. Gastroenterology 1988, 95(2):434-440.
7. Kiyosue H., Mori H., Matsumoto S., et al. Transcatheter obliteration of gastric varices. Part 1. Anatomic classification. Radiographics 2003, 23(4):911-920.
8. Saad W.E. Vascular anatomy and the morphologic and hemodynamic classifications of gastric varices and spontaneous portosystemic shunts relevant to the BRTO procedure. Tech Vasc Interv Radiol 2013, 16(2):60-100.
9. Tan P.C., Hou M.C., Lin H.C., et al. Arandomized trial of endoscopic treatment of acute gastric variceal hemorrhage: N-butyl-2-cyanoacrylate injection versus band ligation. Hepatology 2006, 43(4):690-697.
10. Rajoriya N., Forrest E.H., Gray J., et al. Long-term follow-up of endoscopic Histoacryl glue injection for the management of gastric variceal bleeding. QJM 2011, 104(1):41-47.
11. Lo G.H., Lai K.H., Cheng J.S., et al. Aprospective, randomized trial of butyl cyanoacrylate injection versus band ligation in the management of bleeding gastric varices. Hepatology 2001, 33(5):1060-1064.
12. Hong C.H., Kim H.J., Park J.H., et al. Treatment of patients with gastric varicealhemorrhage: endoscopic N-butyl-2-cyanoacrylate injection versus balloon-occluded retrograde transvenous obliteration. JGastroenterol Hepatol 2009, 24(3):372-378.
13. Caldwell S.H., Hespenheide E.E., Greenwald B.D., et al. Enbucrilate for gastric varices: extended experience in 92 patients. Aliment Pharmacol Ther 2007, 26(1):49-59.
14. Lo G.H., Liang H.L., Chen W.C., et al. Aprospective, randomized controlled trial of transjugular intrahepatic portosystemic shunt versus cyanoacrylate injection in the prevention of gastric variceal rebleeding. Endoscopy 2007, 39(8):679-685.
15. Kang E.J., Jeong S.W., Jang J.Y., et al. Long-term result of endoscopic Histoacryl (N-butyl-2-cyanoacrylate) injection for treatment of gastric varices. World J Gastroenterol 2011, 17(11):1494-1500.
16. Cheng L.F., Wang Z.Q., Li C.Z., et al. Low incidence of complications from endoscopic gastric variceal obturation with butyl cyanoacrylate. Clin Gastroenterol Hepatol 2010, 8(9):760-766.
17. Caldwell S. Gastric varices: is there a role for endoscopic cyanoacrylates, or are we entering the BRTO era?. Am J Gastroenterol 2012, 107(12):1784-1790.
18. Tripathi D., Therapondos G., Jackson E., et al. The role of the transjugular intrahepatic portosystemic stent shunt (TIPSS) in the management of bleeding gastric varices: clinical and haemodynamic correlations. Gut 2002, 51(2):270-274.
19. Sanyal A.J., Freedman A.M., Luketic V.A., et al. The natural history of portal hypertension after transjugular intrahepatic portosystemic shunts. Gastroenterology 1997, 112(3):889-898.
20. Mahadeva S., Bellamy M.C., Kessel D., et al. Cost-effectiveness of N-butyl-2-cyanoacrylate (histoacryl) glue injections versus transjugular intrahepatic portosystemic shunt in the management of acute gastric variceal bleeding. Am J Gastroenterol 2003, 98(12):2688-2693.
21. Procaccini N.J., Al-Osaimi A.M., Northup P., et al. Endoscopic cyanoacrylate versus transjugular intrahepatic portosystemic shunt for gastric variceal bleeding: a single-center U.S. analysis. Gastrointest Endosc 2009, 70(5):881-887.
22. Greenwald B.D., Caldwell S.H., Hespenheide E.E., et al. N-2-butyl-cyanoacrylate for bleeding gastric varices: a United States pilot study and cost analysis. Am J Gastroenterol 2003, 98(9):1982-1988.
23. Ryan B.M., Stockbrugger R.W., Ryan J.M. Apathophysiologic, gastroenterologic, and radiologic approach to the management of gastric varices. Gastroenterology 2004, 126(4):1175-1189.
24. Tripathi D., Jalan R. Transjugular intrahepatic portosystemic stent-shunt in the management of gastric and ectopic varices. Eur J Gastroenterol Hepatol 2006, 18(11):1155-1160.
25. Akahoshi T., Hashizume M., Tomikawa M., et al. Long-term results of balloon-occluded retrograde transvenous obliteration for gastric variceal bleeding and risky gastric varices: a 10-year experience. JGastroenterol Hepatol 2008, 23(11):1702-1709.
26. Hirota S., Matsumoto S., Tomita M., et al. Retrograde transvenous obliteration of gastric varices. Radiology 1999, 211(2):349-356.
27. Hiraga N., Aikata H., Takaki S., et al. The long-term outcome of patients with bleeding gastric varices after balloon-occluded retrograde transvenous obliteration. JGastroenterol 2007, 42(8):663-672.
28. Kitamoto M., Imamura M., Kamada K., et al. Balloon-occluded retrograde transvenous obliteration of gastric fundal varices with hemorrhage. Am J Roentgenol 2002, 178(5):1167-1174.
29. Kim E.S., Kweon Y.O., Cho C.M., et al. The clinical efficacy of the balloon occluded retrograde transvenous obliteration (BRTO) in gastric variceal bleeding. J Hepatol 2003, 38:62.
30. Ninoi T., Nakamura K., Kaminou T., et al. TIPS versus transcatheter sclerotherapy for gastric varices. AJR Am J Roentgenol 2004, 183(2):369-376.
31. Ferral H., Patel N.H. Selection criteria for patients undergoing transjugular intrahepatic portosystemic shunt procedures: current status. JVasc Interv Radiol 2005, 16(4):449-455.
32. Saad W.E., Darwish W.M., Davies M.G., et al. Transjugular intrahepatic portosystemic shunts in liver transplant recipients for management of refractory ascites: clinical outcome. JVasc Interv Radiol 2010, 21(2):218-223.
33. Uehara H., Akahoshi T., Tomikawa M., et al. Prediction of improved liver function after balloon-occluded retrograde transvenous obliteration: relation to hepatic vein pressure gradient. JGastroenterol Hepatol 2012, 27(1):137-141.
34. Kumamoto M., Toyonaga A., Inoue H., et al. Long-term results of balloon-occluded retrograde transvenous obliteration for gastric fundal varices: hepatic deterioration links to portosystemic shunt syndrome. JGastroenterol Hepatol 2010, 25(6):1129-1135.
35. Saad W.E., Wagner C.C., Al-Osaimi A., et al. The effect of balloon-occluded transvenous obliteration of gastric varices and gastrorenal shunts on the hepatic synthetic function: a comparison between Child-Pugh and model for end-stage liver disease scores. Vasc Endovascular Surg 2013, 47(4):281-287.
36. Cho S.K., Shin S.W., Yoo E.Y., et al. The short-term effects of balloon-occluded retrograde transvenous obliteration, for treating gastric variceal bleeding, on portal hypertensive changes: a CT evaluation. Korean J Radiol 2007, 8(6):520-530.
37. Tanihata H., Minamiguchi H., Sato M., et al. Changes in portal systemic pressure gradient after balloon-occluded retrograde transvenous obliteration of gastric varices and aggravation of esophageal varices. Cardiovasc Intervent Radiol 2009, 32(6):1209-1216.
38. Saad W.E., Wagner C.C., Lippert A., et al. Protective value of TIPS against the development of hydrothorax/ascites and upper gastrointestinal bleeding after balloon-occluded retrograde transvenous obliteration (BRTO). Am J Gastroenterol 2013, 108(10):1612-1619.
39. Cho S.K., Shin S.W., Do Y.S., et al. Development of thrombus in the major systemic and portal veins after balloon-occluded retrograde transvenous obliteration for treating gastric variceal bleeding: its frequency and outcome evaluation with CT. JVasc Interv Radiol 2008, 19(4):529-538.
40. Mishra S.R., Chander Sharma B., Kumar A., et al. Endoscopic cyanoacrylate injection versus beta-blocker for secondary prophylaxis of gastric variceal bleed: a randomised controlled trial. Gut 2010, 59(6):729-735.
41. Mishra S.R., Sharma B.C., Kumar A., et al. Primary prophylaxis of gastric variceal bleeding comparing cyanoacrylate injection and beta-blockers: a randomized controlled trial. JHepatol 2011, 54(6):1161-1167.
42. Norton I.D., Andrews J.C., Kamath P.S. Management of ectopic varices. Hepatology 1998, 28(4):1154-1158.
43. Lebrec D., Benhamou J.P. Ectopic varices in portal hypertension. Clin Gastroenterol 1985, 14(1):105-121.
44. Hashizume M., Tanoue K., Ohta M., et al. Vascular anatomy of duodenal varices: angiographic and histopathological assessments. Am J Gastroenterol 1993, 88(11):1942-1945.
45. Al-Mofarreh M., Al-Moagel-Alfarag M., Ashoor T., et al. Duodenal varices. Report of 13 cases. ZGastroenterol 1986, 24(11):673-680.
46. Liu Y., Yang J., Wang J., et al. Clinical characteristics and endoscopic treatment with cyanoacrylate injection in patients with duodenal varices. Scand J Gastroenterol 2009, 44(8):1012-1016.
47. Bhasin D.K., Sharma B.C., Sriram P.V., et al. Endoscopic management of bleeding ectopic varices with histoacryl. HPB Surg 1999, 11(3):171-173.
48. Kim H.H., Kim S.E. Ruptured duodenal varices successfully managed by endoscopic N-butyl-2-cyanoacrylate injection. JClin Med Res 2012, 4(5):351-353.
49. Rai R., Panzer S.W., Miskovsky E., et al. Thrombin injection for bleeding duodenal varices. Am J Gastroenterol 1994, 89(10):1871-1873.
50. Zamora C.A., Sugimoto K., Tsurusaki M., et al. Endovascular obliteration of bleeding duodenal varices in patients with liver cirrhosis. Eur Radiol 2006, 16(1):73-79.
51. Haruta I., Isobe Y., Ueno E., et al. Balloon-occluded retrograde transvenous obliteration (BRTO), a promising nonsurgical therapy for ectopic varices: a case report of successful treatment of duodenal varices by BRTO. Am J Gastroenterol 1996, 91(12):2594-2597.
52. Almeida J.R., Trevisan L., Guerrazzi F., et al. Bleeding duodenal varices successfully treated with TIPS. Dig Dis Sci 2006, 51(10):1738-1741.
53. Kochar N., Tripathi D., McAvoy N.C., et al. Bleeding ectopic varices in cirrhosis: the role of transjugular intrahepatic portosystemic stent shunts. Aliment Pharmacol Ther 2008, 28(3):294-303.
54. Chawla Y., Dilawari J.B. Anorectal varices-their frequency in cirrhotic and non-cirrhotic portal hypertension. Gut 1991, 32(3):309-311.
55. Ganguly S., Sarin S.K., Bhatia V., et al. The prevalence and spectrum of colonic lesions in patients with cirrhotic and noncirrhotic portal hypertension. Hepatology 1995, 21(5):1226-1231.
56. Misra S.P., Dwivedi M., Misra V., et al. Colonic changes in patients with cirrhosis and in patients with extrahepatic portal vein obstruction. Endoscopy 2005, 37(5):454-459.
57. Herman B.E., Baum S., Denobile J., et al. Massive bleeding from rectal varices. Am J Gastroenterol 1993, 88(6):939-942.
58. Chen W.C., Hou M.C., Lin H.C., et al. An endoscopic injection with N-butyl-2-cyanoacrylate used for colonic variceal bleeding: a case report and review of the literature. Am J Gastroenterol 2000, 95(2):540-542.
59. Coelho-Prabhu N., Baron T.H., Kamath P.S. Endoscopic band ligation of rectal varices: a case series. Endoscopy 2010, 42(2):173-176.
60. Ryu S.H., Moon J.S., Kim I., et al. Endoscopic injection sclerotherapy with N-butyl-2-cyanoacrylate in a patient with massive rectal variceal bleeding: a case report. Gastrointest Endosc 2005, 62(4):632-635.
61. Anan A., Irie M., Watanabe H., et al. Colonic varices treated by balloon-occluded retrograde transvenous obliteration in a cirrhotic patient with encephalopathy: a case report. Gastrointest Endosc 2006, 63(6):880-884.
62. Hashimoto N., Akahoshi T., Kamori M., et al. Treatment of bleeding rectal varices with transumbilical venous obliteration of the inferior mesenteric vein. Surg Laparosc Endosc Percutan Tech 2013, 23(3):e134-e137.
63. Vangeli M., Patch D., Terreni N., et al. Bleeding ectopic varices-treatment with transjugular intrahepatic porto-systemic shunt (TIPS) and embolisation. JHepatol 2004, 41(4):560-566.
64. Shibata D., Brophy D.P., Gordon F.D., et al. Transjugular intrahepatic portosystemic shunt for treatment of bleeding ectopic varices with portal hypertension. Dis Colon Rectum 1999, 42(12):1581-1585.
65. Nayar M., Saravanan R., Rowlands P.C., et al. TIPSS in the treatment of ectopic variceal bleeding. Hepatogastroenterology 2006, 53(70):584-587.
66. Merkel C., Bolognesi M., Bellon S., et al. Long-term follow-up study of adult patients with non-cirrhotic obstruction of the portal system: comparison with cirrhotic patients. JHepatol 1992, 15(3):299-303.
67. Condat B., Pessione F., Hillaire S., et al. Current outcome of portal vein thrombosis in adults: risk and benefit of anticoagulant therapy. Gastroenterology 2001, 120(2):490-497.
68. Amitrano L., Guardascione M.A., Scaglione M., et al. Prognostic factors in noncirrhotic patients with splanchnic vein thromboses. Am J Gastroenterol 2007, 102(11):2464-2470.
69. Janssen H.L., Wijnhoud A., Haagsma E.B., et al. Extrahepatic portal vein thrombosis: aetiology and determinants of survival. Gut 2001, 49(5):720-724.
70. Rodriguez-Castro K.I., Porte R.J., Nadal E., et al. Management of nonneoplastic portal vein thrombosis in the setting of liver transplantation: a systematic review. Transplantation 2012, 94(11):1145-1153.
71. Francoz C., Belghiti J., Vilgrain V., et al. Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation. Gut 2005, 54(5):691-697.
72. Zocco M.A., Di Stasio E., De Cristofaro R., et al. Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development. JHepatol 2009, 51(4):682-689.
73. Amitrano L., Guardascione M.A., Brancaccio V., et al. Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis. JHepatol 2004, 40(5):736-741.
74. Senzolo M., Sartori T., Rossetto V., et al. Prospective evaluation of anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis. Liver Int 2012, 32(6):919-927.
75. Amitrano L., Guardascione M.A., Menchise A., et al. Safety and efficacy of anticoagulation therapy with low molecular weight heparin for portal vein thrombosis in patients with liver cirrhosis. JClin Gastroenterol 2010, 44(6):448-451.
76. Valla D.C., Condat B., Lebrec D. Spectrum of portal vein thrombosis in the West. JGastroenterol Hepatol 2002, 17(Suppl 3):S224-S227.
77. Sarin S.K., Sollano J.D., Chawla Y.K., et al. Consensus on extra-hepatic portal vein obstruction. Liver Int 2006, 26(5):512-519.
78. Orr D.W., Harrison P.M., Devlin J., et al. Chronic mesenteric venous thrombosis: evaluation and determinants of survival during long-term follow-up. Clin Gastroenterol Hepatol 2007, 5(1):80-86.
79. Spaander V.M., van Buuren H.R., Janssen H.L. Review article: the management of non-cirrhotic non-malignant portal vein thrombosis and concurrent portal hypertension in adults. Aliment Pharmacol Ther 2007, 26(Suppl 2):203-209.
80. Spaander M.C., Darwish Murad S., van Buuren H.R., et al. Endoscopic treatment of esophagogastric variceal bleeding in patients with noncirrhotic extrahepatic portal vein thrombosis: a long-term follow-up study. Gastrointest Endosc 2008, 67(6):821-827.
81. Primignani M. Portal vein thrombosis, revisited. Dig Liver Dis 2010, 42(3):163-170.
82. Primignani M., Martinelli I., Bucciarelli P., et al. Risk factors for thrombophilia in extrahepatic portal vein obstruction. Hepatology 2005, 41(3):603-608.
83. Primignani M., Mannucci P.M. The role of thrombophilia in splanchnic vein thrombosis. Semin Liver Dis 2008, 28(3):293-301.
84. De Stefano V., Teofili L., Leone G., et al. Spontaneous erythroid colony formation as the clue to an underlying myeloproliferative disorder in patients with Budd-Chiari syndrome or portal vein thrombosis. Semin Thromb Hemost 1997, 23(5):411-418.
85. Colaizzo D., Amitrano L., Tiscia G.L., et al. The JAK2 V617F mutation frequently occurs in patients with portal and mesenteric venous thrombosis. JThromb Haemost 2007, 5(1):55-61.
86. de Franchis R., Baveno V.F. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. JHepatol 2010, 53(4):762-768.
87. Plessier A., Darwish-Murad S., Hernandez-Guerra M., et al. Acute portal vein thrombosis unrelated to cirrhosis: a prospective multicenter follow-up study. Hepatology 2010, 51(1):210-218.
88. Hall T.C., Garcea G., Metcalfe M., et al. Impact of anticoagulation on outcomes in acute non-cirrhotic and non-malignant portal vein thrombosis: a retrospective observational study. Hepatogastroenterology 2013, 60(122):311-317.
89. Garcia-Pagan J.C., Hernandez-Guerra M., Bosch J. Extrahepatic portal vein thrombosis. Semin Liver Dis 2008, 28(3):282-292.
90. Condat B., Pessione F., Helene Denninger M., et al. Recent portal or mesenteric venous thrombosis: increased recognition and frequent recanalization on anticoagulant therapy. Hepatology 2000, 32(3):466-470.
91. Turnes J., Garcia-Pagan J.C., Gonzalez M., et al. Portal hypertension-related complications after acute portal vein thrombosis: impact of early anticoagulation. Clin Gastroenterol Hepatol 2008, 6(12):1412-1417.
92. Donadini M.P., Dentali F., Ageno W. Splanchnic vein thrombosis: new risk factors and management. Thromb Res 2012, 129(Suppl 1):S93-S96.
93. Heider T.R., Azeem S., Galanko J.A., et al. The natural history of pancreatitis-induced splenic vein thrombosis. Ann Surg 2004, 239(6):876-880. [discussion: 880-2].
94. Bernades P., Baetz A., Levy P., et al. Splenic and portal venous obstruction in chronic pancreatitis. A prospective longitudinal study of a medical-surgical series of 266 patients. Dig Dis Sci 1992, 37(3):340-346.
95. Bradley E.L. The natural history of splenic vein thrombosis due to chronic pancreatitis: indications for surgery. Int J Pancreatol 1987, 2(2):87-92.
96. Butler J.R., Eckert G.J., Zyromski N.J., et al. Natural history of pancreatitis-induced splenic vein thrombosis: a systematic review and meta-analysis of its incidence and rate of gastrointestinal bleeding. HPB (Oxford) 2011, 13(12):839-845.
97. Weber S.M., Rikkers L.F. Splenic vein thrombosis and gastrointestinal bleeding in chronic pancreatitis. World J Surg 2003, 27(11):1271-1274.
98. Agarwal A.K., Raj Kumar K., Agarwal S., et al. Significance of splenic vein thrombosis in chronic pancreatitis. Am J Surg 2008, 196(2):149-154.
99. Sakorafas G.H., Sarr M.G., Farley D.R., et al. The significance of sinistral portal hypertension complicating chronic pancreatitis. Am J Surg 2000, 179(2):129-133.